Jean W. Frydman's blog post, " FDA Approves Second Biosimilar Drug Since the Biologic Price Competition and Innovation Act of 2009 Was Passed," originally posted in the firm's Emerging Companies Insider blog, was mentioned as one of the top postings for May 03, 2016.
View full article here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.